1 December is World AIDS Day.
Acquired Immunodeficiency Syndrome (AIDS) is a consequence of infection with the Human Immunodeficiency Virus (HIV) which is estimated to infect 3.7 million people around the world. The virus targets the immune system and causes the demise of the T cells, which help coordinate immune responses, leaving individuals extremely susceptible to other infections and diseases.
To raise awareness of AIDS, how it affects people’s lives and how immunology research can help to develop new diagnostics and treatments, on World AIDS Day, the British Society for Immunology is highlighting some of our recent resources and publications on social media throughout the day.
Highlights of our resources:
- The hunt for an HIV vaccine. Read this fascinating article from our 60th anniversary report discussing how developing a vaccine against HIV represented the biggest biomedical challenge of the generation, and the early disappointments and new approaches undertaken.
- Diagnosing HIV – how does it work? A blog post from a previous World AIDS Day which explores the tests currently used to diagnose HIV, how they work and how you can access them.
- Our BiteSized Immunology resource has a number of related articles, including Human Immunodeficiency Virus (HIV) and HIV-1 Vaccines.
- A range of articles published in our journals Immunology and Clinical & Experimental Immunology:
- Nasi et al 2016 Ageing and inflammation in patients with HIV infection. Clinical & Experimental Immunology 187 44-52 (free to read)
- Ruffin et al 2017 From dendritic cells to B cells dysfunctions during HIV-1 infection: T follicular helper cells at the crossroads Immunology 151 137-145 (free to read)
- Ambada et al 2017 Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people Immunology 151 405-416
- Jaumdally et al 2017 CCR5 expression, haplotype and immune activation in protection from infection in HIV-exposed uninfected individuals in HIV-serodiscordant relationships Immunology 151 464-473
- Murday et al 2017 Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen Immunology 151 385-394
- Lisovsky et al 2016 The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in vitro HIV infection Clinical & Experimental Immunology 186 336-346
- Lisovsky et al 2016 Partial recovery of senescence and differentiation disturbances in CD8+ T cell effector-memory cells in HIV-1 infection after initiation of anti-retroviral treatment Clinical & Experimental Immunology 186 227-238 (free to read)
- Gooneratne et al 2016 Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation Clinical & Experimental Immunology 184 101-109 (free to read)
Follow our social media channels to find out more:
- BSI Twitter channel - @britsocimm
- BSI Facebook page
- BSI Instagram page - britsocimm
- Clinical & Experimental Immunology journal Twitter channel - @CEIjournal
- Immunology journal Twitter channel - @immjournal